Oncology Nursing Society (ONS) has updated its Oncology Nursing Society Seal of Approval™ program, which provides additional benefits to companies interested in promoting nurse and patient support materials. Companies that submit materials and are approved can prominently display the Oncology Nursing Society Seal of Approval logo on marketing collateral for distribution to nurses and patients.

Dear Members,

At our June 4–5, 2020, meeting, the ONS Board discussed our personal heartbreak and anger over the death of George Floyd and other black Americans by aggressive police activity driven by racism. We also discussed ONS’s role and responsibilities as a member organization.

Get to know Kristin Ferguson, DNP, RN, OCN^®, treasurer on the ONS Board of Directors from 2019–2021 and director-at-large from 2019–2022. Kristin is the clinical operations manager/nurse manager III at MedStar Georgetown University Hospital Lombardi Comprehensive Cancer Center in Washington, DC.

PITTSBURGH, PA—June 10, 2020—The COVID-19 coronavirus pandemic forced oncology nurses to navigate abnormal circumstances, both at home and at work. Despite facing similar limitations, the Oncology Nursing Society (ONS) created a brand-new learning experience to give oncology nurses expert education, networking opportunities, and access to industry representatives in the wake of canceled in-person events. This September, ONS will host the inaugural ONS Bridge™, the most comprehensive conference dedicated to oncology nurses.

In honor of Oncology Nursing Month, the Oncology Nursing Society (ONS) announced today the two awardees selected in the Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology. The Challenge was designed with the goal of accelerating innovation in improving oncology care, including prevention, early detection, treatment, and care for cancer survivors. 

May 8, 2020—Oncology Nursing Society member Betty Ferrell, PhD, MA, FAAN, FPCN, director of the division of nursing research and education at City of Hope in Duarte, CA, was one of 14 recipients of an American Society of Clinical Oncology (ASCO) special award in April 2020. She received the Walther Cancer Foundation Palliative and Supportive Care in Oncology Endowed Award and Lecture for her work in palliative care.

Get to know Martha (Marty) Polovich, PhD, RN, director-at-large on the ONS Board of Directors from 2019–2022. Marty is a part-time instructor in the Byrdine F. Lewis College of Nursing and Health Professions at Georgia State University in Atlanta.

Get to know Heather Thompson Mackey, MSN, ANP-BC, AOCN^®, secretary on the ONS Board of Directors from 2019–2021 and director-at-large from 2018–2021. Heather is the clinical editor in oncology for Elsevier and a nurse practitioner for Novant Health Cancer Prevention and Wellness in Winston-Salem, NC.

(April 2, 2020)—Chemotherapy is one of the most successful forms of cancer treatment available, but it’s frequently thought of as deadly and dangerous because of its hazardous chemical properties and potential for severe side effects in patients. What’s often left out of the chemotherapy conversation is the danger it poses to healthcare workers handling the hazardous medications. In two new articles published in the Oncology Nursing Forum, Oncology Nursing Society (ONS) member AnnMarie Walton, PhD, MPH, RN, OCN®, CHES, assistant professor in the School of Nursing at Duke University in Durham, NC, helped healthcare professionals understand the risks and needs for proper safe handling for chemotherapy. 

Get to know Anne M. Ireland, MSN, RN, AOCN^®, CENP, director-at-large on the ONS Board of Directors from 2018–2021. Anne is the executive director for community nursing practice at the City of Hope National Medical Center in Duarte, CA.

During its December 2019 conference call, the ONS Board of Directors conducted annual reviews of positions, policies, and performance. Here are the outcomes that affect ONS members.

After busy Thanksgiving get-togethers and frantic Black Friday, Small-Business Saturday, and Cyber Monday shopping, many people take a moment to reflect and give back to a cause that captures their passion. Dubbed Giving Tuesday, it’s a day dedicated to philanthropy and fundraising. For the first time ever, the Oncology Nursing Foundation issued a Giving Tuesday challenge to ONS chapters—a friendly competition to see which group could get the highest percentage of its membership to donate to the continued growth and excellence of oncology nursing. When all was said and done, 30 ONS chapters helped raise more than $19,000 to support the education, research, and leadership development of oncology nurses everywhere.

Connection, creativity, and change were just some of the components of the ONS Board of Directors’ third-quarter face-to-face meeting held October 31–November 3, 2019. In addition to their regular agenda, the ONS Board conducted enterprise-wide joint and individual meetings with the Oncology Nursing Certification Corporation and Oncology Nursing Foundation boards.

To continue to guide the future path of the Oncology Nursing Society (ONS) and its commitment to innovation, advocacy, and excellence in the nursing profession, the ONS Board of Directors has elected Memorial Sloan Kettering Cancer Center (MSK) Director of Nursing, Evidence-Based Practice, Nancy Houlihan, MA, RN, AOCN^®, as the Society’s next president. Houlihan will succeed Laura Fennimore, DNP, RN, NEA-BC, professor of acute and tertiary care at the University of Pittsburgh School of Nursing, who concludes her two-year tenure as president on April 29, 2020, at ONS’s 45th Annual Congress in San Antonio, TX.

As a trailblazer and pioneer in palliative care and end-of-life research, ONS member Betty Ferrell, PhD, MA, FAAN, FPCN, director of the division of nursing research and education at City of Hope in Duarte, CA, has improved the quality of life for countless patients with cancer throughout the world. In recognition of her vast contributions to oncology nursing science and patient-centered care, Ferrell was elected to the National Academy of Medicine, one of the highest medical honors in the United States, on October 21, 2019. She joins the ranks of only 2,200 other medical professionals to be appointed to the Academy.

While looking for an image for a presentation, I came across this quote on a picture of a woman whose hands were more than full. It captured the message I was going to be giving. The world of health care, specifically cancer care, continues to evolve rapidly from an array of forces outside of our control. However, in that swirl of change, we have the opportunity to evaluate any resulting barriers or challenges to patient care and to design and implement solutions. To do this, to be creative, to innovate, to problem solve, we may have to let go of things with which we are comfortable but are not of benefit in today’s world.

The preliminary outcomes for performance in the first year of the Oncology Care Model (OCM) have shown modest but interesting results for the value-based payment model. Centers for Medicare and Medicaid Services’ year-one evaluation examined the initial impact of the new payment model on practice in terms of outcomes related to total cost of care per practice, unplanned hospital and emergency department visits, hospital visits, and patient-reported satisfaction with care for six-month episodes of chemotherapy for beneficiaries from July 1, 2016–June 30, 2017.

Using a predetermined formula, the ONS Board of Directors annually evaluates membership dues to ensure the levels will enable the Society to continue to provide ONS members with the high-quality products, services, and resources they need to transform care for patients with cancer. Based on the formula, the Board decided to maintain dues at the 2019 level for 2020.

Oncology nursing-led research is the engine that drives practice change when caring for patients with cancer. As a standard-bearer of oncology nursing research and a veteran of nursing research publications, Debra Lyon, RN, PhD, FNP-BC, FAAN, will bring a wealth of expertise and experience to the Oncology Nursing Forum (ONF), becoming the research journal’s sixth editor effective January 1, 2020.

A few weeks in July and August are known as the dog days of summer—the days where the heat makes us feel particularly laid back and lazy. I have always thought that these hottest days of the year, when even dogs languished from the heat, gave us a chance to slow down and offered a break from the intensity of work or school. It was a time for families to enjoy relaxing vacations and children to make memories of new friendships and adventures. I decided to Google the meaning of dog days and lazy days. I found that the term lazy days was similar to my thinking, but dog days has a different meaning. 

ONS member Ruth McCorkle, PhD, RN, FAPOS, FAAN, had a storied, trailblazing career in oncology nursing, leading the way to advance nursing research, patient-centered care, and educational excellence. McCorkle passed away on August 17, 2019, surrounded by her close family, leaving behind an indelible legacy to the oncology nursing profession.        

ONS wrapped up the first four months of 2019 as a financially strong organization, according to the finance reports the ONS Board of Directors received during its June 13–15 meeting. The Society’s investments are up almost 9%. It also saw an increase in ONS Congress revenue from 2018 to 2019 and will not raise Congress registration fees for 2020. A solid financial outlook allows ONS to continue to serve its members by representing and growing the profession. 
 

Leadership, integrity, inclusion, and diversity were common threads in several discussions during the ONS Board of Directors’ conference call on May 21, 2019. In addition to finalizing plans for their participation in the Leadership Think Tank, which will be held on July 22–23, 2019, the Board made the following decisions and approvals. 

On Sunday, April 14, 2019, the ONS Board of Directors held a face-to-face meeting at the end of a highly successful ONS 44th Annual Congress in Anaheim, CA. New directors took office and new plans unfolded for fostering nurse leaders and supporting ONS chapters.

Professional development needs of oncology nurse navigators (ONNs) have not been clearly identified, both for novice and more experienced navigators. Although some work has begun to define training for novice ONNs, most information about education for experienced ONNs comes from evaluation data and anecdotal reports.    

As a vanguard for oncology nursing certification and practice excellence, Cynthia Miller Murphy, MSN, RN, CAE, FAAN, executive director for the Oncology Nursing Certification Corporation (ONCC), is a nationally recognized expert in credentialing. Her tenure as ONCC executive director helped nurses achieve more than 100,000 different certifications to demonstrate their commitment to excellence in nursing and patient-centered care. After almost 30 years at ONCC, Miller Murphy is retiring as executive director effective April 8, 2019. 

Although cancer isn’t one of the very highest causes of death in Azerbaijan, the nation still feels the impact of the global cancer burden: lung cancer and gastrointestinal cancers rank number 8 and 10, respectively, on the top 10 causes of death in the country, and their incidence is growing. As part of its commitment to sustainable international programs to support the advancement of cancer care, ONS and its members have a responsibility to disseminate knowledge to international nurses in countries like Azerbaijan. 

Oncology nurses have seen many changes in the past decade with significant improvements in cancer treatment, better symptom management and palliative care, and enhanced care coordination. But much work needs to be done as we look toward the future.

Before the hustle and bustle of the holiday season, I wanted to thank you, our ONS members, for advancing the voice and contributions of oncology nurses to critical issues in cancer care.

From her patients to her colleagues to the entire cancer care community, ONS Past President Sandra Lee Schafer, RN, MN, AOCN^®, made everyone she touched feel special, inspiring and motivating a generation of oncology nurses in advancing care for patients with cancer. Schafer passed away on December 7, 2018, but her legacy of compassion and care lives on.

During the October 2018 board meeting held at the national office, the ONS Board of Directors heard reports from leadership and status reports on research and evidence-based practice work, discussed key initiatives, received an update from the Oncology Nursing Foundation, and reviewed and approved the Society’s operating budget for 2019. Additionally, two key generative discussions focused on the ongoing implementation of ONS chapter model changes and a review and strategy session around ONS position statements.

On an unseasonably warm Saturday in October, Pittsburgh, PA, was struck by one of the United States’ greatest tragedies in recent history. The shooting at the Tree of Life Synagogue in Squirrel Hill—a quiet, unassuming neighborhood in the heart of the city—sent shockwaves through the community, the country, and the world. On October 24, 2018, one man’s attack violently stole 11 lives from the Jewish community.

What comes to mind when someone mentions Brazil? Do you think soccer? The 2016 Rio Olympics? Carnival? The Amazon rainforest? Although all of those are true, even more impressive is what’s happening in oncology nursing throughout Brazil. In August 2018, a small group of dedicated Brazilian oncology nurses—many of whom are ONS members—hosted the Inaugural Oncology Nursing Brazil 2018 conference in Sao Paulo.

Discussion of ONS’s financial health was a key item on the agenda for the July 2018 Board of Directors meeting. As one of the quarterly face-to-face meetings the Board holds in conjunction with ONS Leadership Weekend, the meeting also provided the opportunity for in-depth discussion around several additional topics.

Long-time ONS member and oncology nurse scientist Karen Meneses, PhD, RN, FAAN, Professor and Associate Dean for Research at the School of Nursing at the University of Alabama at Birmingham (UAB) passed away unexpectedly on August 1, 2018.

Nurse practitioners (NPs) are key to improving the quality of care for their patients with cancer through advocacy—both in institutions across the country and in legislative offices on Capitol Hill. With the intent to remove barriers so NPs can help move the needle for healthcare policy, ONS’s Center for Advocacy and Health Policy held the summit, “Policy Barriers and Opportunities to NPs in Oncology,” on April 10, 2018, in Washington, DC.

Whether being called on to inform the National Cancer Moonshot Initiative, develop novel resources for patients with prostate cancer, or create programs for smoking cessation, nurse scientists are continually advancing patient-centered oncology care. Nurse researcher contributions have led to improved patient outcomes, better symptom management interventions, and overall quality of care. As part of its commitment to future nursing research, ONS created a new scholar-in-residence position to drive and inform the Society’s research agenda and highlight the integral work of ONS member nurse scientists who are moving the needle for patients with cancer.

Because the treatment of symptoms, side effects, and adverse events associated with immunotherapies can differ greatly from the standard of care, the American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN)—along with experts from ONS staff and membership—collaborated to develop guidelines to inform clinicians about managing immune-related adverse events associated with checkpoint inhibitor therapy.

On its January conference call, the ONS Board of Directors completed work that will guide ONS leadership for the future.